Table 1.
AIE | Bacterial | Fungal | Viral | Total | p‐value | p‐value for AIE versus IE | |
---|---|---|---|---|---|---|---|
Number of patients | 79 | 41 | 10 | 95 | 225 | ||
Age at presentation | |||||||
Median (Q1, Q3) Min–Max |
59.5 (42, 70) 17–88 |
66 (61, 77) 35–91 |
36.5 (31, 44.8) 25–67 |
70 (58.5, 81.5) 25–94 |
65 (47, 76) 17–94 |
<1e‐04 |
0.0006 |
Female sex (%) | 38 (48.1%) | 22 (53.7%) | 3 (30.0%) | 36 (37.9%) | 99 (44.0%) | 0.2349 | 0.3998 |
mRS prior | |||||||
≤2 (%) | 79 (100.0%) | 32 (78.0%) | 8 (80.0%) | 79 (83.2%) | 198 (88.0%) | 0.0005 | <1e‐04 |
>2 (%) | 0 (0.0%) | 9 (22.0%) | 2 (20.0%) | 16 (16.8%) | 27 (12.0%) |
AIE, autoimmune encephalitis; IE, infectious encephalitis; mRS, modified Rankin Score.